dar-100a
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT01466205)
Timeline
Indications
Mechanism of action
- Dopamine D1 receptorAGONIST
DRD1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dar 0-100a
- dar-100a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02507206 | Phase 2 | Apr 1, 2013 | Columbia University, Icahn School of Medicine at Mount Sinai, National Institute of Mental Health (NIMH) |
| NCT01519557 | Early Phase 1 (Phase 1) | Apr 1, 2011 | Columbia University |
| NCT01466205 | Phase 2 | Jan 1, 2011 | Columbia University, Department of Veteran Affairs, Icahn School of Medicine at Mount Sinai |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 3 | 1 | 2 | 2011 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 2 | 2 | 1 | 2011 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2011 |
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1